Invention Grant
- Patent Title: JAK kinase modulating compounds and methods of use thereof
-
Application No.: US12714323Application Date: 2010-02-26
-
Publication No.: US08349851B2Publication Date: 2013-01-08
- Inventor: Sunny Abraham , Qi Chao , Michael J. Hadd , Mark W. Holladay , Gang Liu , Eduardo Setti
- Applicant: Sunny Abraham , Qi Chao , Michael J. Hadd , Mark W. Holladay , Gang Liu , Eduardo Setti
- Applicant Address: US CA San Diego
- Assignee: Ambit Biosciences Corp.
- Current Assignee: Ambit Biosciences Corp.
- Current Assignee Address: US CA San Diego
- Agency: Jones Day
- Main IPC: A61K31/517
- IPC: A61K31/517
Abstract:
Provided herein are quinazoline compounds of formula (I): The compounds are useful for treatment of JAK kinase mediated diseases, including JAK2 kinase-, JAK3 kinase- or TYK2 kinase-mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.
Public/Granted literature
- US20100317659A1 JAK KINASE MODULATING COMPOUNDS AND METHODS OF USE THEREOF Public/Granted day:2010-12-16
Information query
IPC分类:
